Martin Hutchings

机构：University of Copenhagen, Copenhagen University Hospital, Rigshospitalet · ORCID：0000-0003-3873-1741

发表论文 408 篇 · 总被引 16251 次 · h-index 55

代表论文

• Efficacy and Safety of Glofitamab Plus Polatuzumab Vedotin in Relapsed/Refractory Large B-Cell Lymphoma Including High-Grade B-Cell Lymphoma: Results From a Phase Ib/II Trial (2025 · Journal of Clinical Oncology · 被引 13)
• Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma (2025 · Blood · 被引 10)
• An Individualized Prediction Model for Early-Stage Classic Hodgkin’s Lymphoma (2025 · NEJM Evidence · 被引 4)
• Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020 (2025 · Haematologica · 被引 3)
• 240 | EPCORITAMAB MONOTHERAPY DEMONSTRATES DEEP AND DURABLE RESPONSES AT 3‐YEAR FOLLOW‐UP IN PATIENTS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (2025 · Hematological Oncology · 被引 3)
• Changes in Lean Muscle Mass, Muscle Strength, and Physical Performance Following First‐Line Chemotherapy in Patients With Lymphoma (2025 · Hematological Oncology · 被引 2)